Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational study
程序性死亡配体1肿瘤比例评分在预测PD-1/PD-L1抗体疗法治疗晚期非小细胞肺癌患者的安全性和有效性中的应用：一项回顾性、多中心、观察性研究
期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003620
Shi, Yuequan; Liu, Xiaoyan; Liu, Anwen; Fang, Jian; Meng, Qingwei; Ding, Cuimin; Ai, Bin; Gu, Yangchun; Zhang, Cuiying; Zhou, Chengzhi; Wang, Yan; Shui, Yongjie; Yu, Siyuan; Zhang, Dongming; Liu, Jia; Zhang, Haoran; Zhou, Qing; Gao, Xiaoxing; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Xu, Yan; Wang, Mengzhao
